A NEW CLASS OF THE ANTI-ISCHEMIC MEDICAMENTS - METABOLIC CYTOPROTECTIVE OF THE CARDIOMYOCYTE

A great imporfance of The coronary disease makes welcome any rationalinnovation in the therapy as is the case with a group of medicaments for the myocardecytoprotection primary!y by the metabolic effect; the best known of them istrimethazidine. The demand for it is obvious since even about 40% of th...

Full description

Bibliographic Details
Main Authors: Svetlana Apostolovic, Lazar Todorovic, Mirko Burazor, Miloje Tomasevic, Slađana Andrejevic, Goran Kovacevic, Jozef Glasnovic, Nevena Karanovic, Dejan Sakac
Format: Article
Language:English
Published: University in Nis, Faculty of Medicine 2000-09-01
Series:Acta Medica Medianae
Subjects:
Online Access:http://publisher.medfak.ni.ac.rs/2000-html/5-broj/NOVA%20KLASA%20ANTIISHEMIJSKIH....pdf